Pfizer Expects Pliant Partners: Deferring To Pfizer Skills And Strengths
Executive Summary
Pfizer expects its partners to defer to Pfizer in areas where it has a clear advantage in established skills and size, rather than push the joint arrangements as a way for the smaller firm to develop new functions
You may also be interested in...
Pfizer Partnership Philosophy Relies On One Manager, Five “C”s
Pfizer relies on one manager to oversee all aspects of an R&D agreement to help ensure that the goals identified in creating the partnership translate into day-to-day practice
Pfizer Partnership Philosophy Relies On One Manager, Five “C”s
Pfizer relies on one manager to oversee all aspects of an R&D agreement to help ensure that the goals identified in creating the partnership translate into day-to-day practice
NPS/Enzon Merger Provides Additional Leverage In Search For Preos Partner
The NPS/Enzon $1.6 bil. merger deal provides more leverage to the companies' search for a partner for the osteoporosis treatment Preos